Genomic organization and chromosome localization of the human cathepsin K gene (CTSK)

Genomics

Volumn 41, Issue 2, 1997, Pages 169-176

  Rood, Julie A ^a   Van Horn, Stephanie ^a   Drake, Fred H ^a   Gowen, Maxine ^a   Debouck, Christine ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; CYSTEINE PROTEINASE; DNA; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1Q; GENE STRUCTURE; GENOME; HUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0031569846     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.4614     Document Type: Article

References (52)

1. Baron, R., Vignery, A., and Horowitz, M. (1984). Lymphocytes, macrophages and the regulation of bone remodeling. In "Bone and Mineral Research Annual 2" (W. A. Peck, Ed.), pp. 175-243, Elsevier, Amsterdam.
2. Berquin I. M., Cao, L., Fong, D., and Sloane B. F. (1995). Identification of two exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene. Gene 159: 143-149.
3. Birnstiel, M. L., Busslinger, M., and Strub, K. (1985). Transcription termination and 3′ processing: The end is in site. Cell 41: 349-359.
4. Blackwell, J. M., Barton, C. H., White, J. K., Searle, S., Baker, A. M., Williams, H., and Shaw, M. A. (1995). Genomic organization and sequence of the human NRAMP gene: Identification and mapping of a promoter region polymorphism. Mol. Med. 1: 194-205.
5. Blake, C. M., Jambou, R. C., Swick, A. G., Kahn, J. W., and Azizkhan, J. C. (1990). Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol. Cell. Biol. 10: 6632-6641.
6. Bossard, M. J., Tomaszek, T. A., Thompson, S. K., Amegadzie, B. Y., Hanning, C. R., Jones, C., Kurdyla, J. T., McNulty, D. E., Drake, F. H., Gowen, M., and Levy, M. A. (1996). Proteolytic activity of human osteoclast cathepsin K. J. Biol. Chem. 271: 12517-12524.
7. Breathnach, R., and Chambon, P. (1981). Organization and expression of eucaryotic split genes coding for proteins. Annu. Rev. Biochem. 50: 349-383.
8. Brömme, D., and Okamoto, K. (1995). Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol. Chem. Hoppe Seylor 376: 379-384.
9. Brömme, D., Okamoto, K., Wang, B. B., and Biroc, S. (1996). Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. J. Biol. Chem. 271: 2126-2132.
10. n polymorphisms in the human dystrophin gene and their implications in carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophies. Genomics 21: 567-570.
11. Chauhan, S. S., Popescu, N. C., Ray, D., Fleischmann, R., Gottesman, M. M., and Troen, B. R. (1993). Cloning, genomic organization, and chromosomal localization of cathepsin L. J. Biol. Chem. 263: 1039-1045.
12. Debari, K., Sasaki, T., Udagawa, N., and Rifkin, B. R. (1995). An ultrastructural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions. Calcif. Tissue Int. 56: 566-570.
13. Delaisse, J. M., Eeckhout, Y., and Vaes, G. (1980). Inhibition of bone resorption and culture by inhibitors of thiol proteinases. Biochem. J. 192: 365-368.
14. Delaisse, J. M., Eeckout, Y., and Vaes, G. (1984). In vitro and in vivo evidence for the involvement of cysteine proteinases in bone resorption. Biochem. Biophys. Res. Commun. 125: 441-447.
15. Delaisse, J. M., Boyde, A., Maconnachie, E., Ali, N. N., Sear, C. H. J., Eeckhout, Y., Vaes, G., and Jones, S. J. (1987). The effects of inhibitors of cysteine proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8: 305-313.
16. Dempster, D. W., and Lindsay, R. (1993). Pathogenesis of osteoporosis. Lancet 341: 797-801.
17. Drake, F. H., Dodds, R. A., James, I. E., Connor, J. R., Debouck, C., Richardson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., Hastings, G., and Gowen, M. (1996). Cathepsin K., but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 271: 12511-12516.
18. Everts, V., Delaisse, J. M., Korper, W., Niehof, A., Vaes, G., and Beertsen, W. (1992). Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J. Cell Physiol. 150:221-231.
19. Faisst, S., and Meyer, S. (1992). Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20(1): 3-26.
20. Gelb, B. D., Shi, G. P., Chapman, H. A., and Desnick, R. J. (1996). Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273: 1236-1238.
21. Ghosh, D. (1990). A relational database of transcription factors. Nucleic Acids Res. 18(7): 1749-1756.
22. Gum, R., Lengyel, E., Juarex, J., Chen, J. H., Sato, H., Seiki, M., and Boyd, D. (1996). Stimulation of 92-kDA gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/e£s and AP-1 sequences. J. Biol. Chem. 271: 10672-10680.
23. Hill, P. A., Buttle, D. J., Jones, S. J., Boyde, A., Murata, M., Reynolds, J. J., and Meikle, M. C. (1994). Inhibition of bone resorption by selective inactivators of cysteine proteinases. J. Cell Biochem. 56: 118-130.
24. Inaoka, T., Bilbe, G., Ishibashi, O., Tezuka, K., Kumegawa, J., and Kokubo, T. (1995). Molecular cloning of human cDNAfor cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem. Biophys. Res. Commun. 206: 89-96.
25. Javahery, R., Khachi, A., Lo, K., Zenzie-Gregory, and Smale, S. T. (1994). DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell Biol. 14: 116-127.
26. Kadonaga, J. T., Jones, K. A., and Tjian, R. (1986). Promoter-specific activation of RNA polymerase II transcription by SP1. Trends Biochem. Sci. 11: 20-23.
27. Lerner, U. H., and Grubb, A. (1992). Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy. J. Bone Miner. Res. 7: 433-439.
28. Li, Y. P., Alexander, M., Wucherpfennig, A. L., Yelick, P., Chen, W., and Stashenko, P. (1995). Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J. Bone Miner. Res. 10: 1197-1202.
29. Manolagas, S. C. (1995). Role of cytokines in bone resorption. Bone 17: 63-67.
30. Manolagas, S. C., Bellido, T., and Jilka, R. L. (1995). New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: Roles of IL-6 and gp130. Int. J. Immunopharmacol. 17: 109-116.
31. Maroulakou, I. G., Papas, T. S., and Green, J. E. (1994). Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene 9: 1551-1565.
32. de la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyece, B. F., Mundy, G. R., and Roodman, G. D. (1995). Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J. Clin. Invest. 95: 2846-2852.
33. Mount, S. M. (1982). A catalogue of splice junction sequences. Nucleic Acids Res. 10: 459-471.
34. Page, A. E., Hayman, A. R., Andersson, L. M. B., Chambers, T. J., and Warburton, M. J. (1993). Degradation of bone matrix proteins by osteoclast cathepsins. Int. J. Biochem. 25: 545-550.
35. Parfitt, A. M., Mundy, G. R., Roodman, G. D., Hughes, D. E., and Boyce, B. F. (1996). A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J. Bone Miner. Res. 11: 150-159.
36. Patthy, L. (1987). Intron-dependent evolution: Preferred types of exons and introns. FEBS Lett. 214(1): 1-7.
37. Pilz, D. T., Dalton, A., Long, A., Jaspan, T., Maltby, E. L., and Quarrell, O. W. (1995). Detecting deletions in the critical region for lissencephaly on 17p13.3 using fluorescent in situ hybridisation and a PCR assay identifying a dinucleotide repeat polymorphism. J. Med. Genet. 32: 275-278.
38. Reddy, S. V., Scarcez, T., Windle, J. J., Leach, R. J., Hundley, J. E., Chirgwin, J. M., Chou, J. Y., and Roodman, G. D. (1993). Cloning and characterization of the 5′ flanking region of the mouse tartrate-resistant acid phosphatase gene. J. Bone Miner. Res. 8: 1263-1270.
39. Reddy, S.V., Kuzhandaivelu, N., Acosta, L. G., and Roodman, G. D. (1995). Characterization of the 5′ flanking region of the human tartrate-resistant acid phosphatase (TRAP) gene. Bone 16: 587-593.
40. Reynolds, G. A., Basu, S. K., Osborne, R. F., Chin, D. J., Gil, G., Brown, M. S., Goldstein, J. L., and Luskey, K. (1984). HMG CoA Reductase: A negatively regulated gene with unusual promoter and 5′ untranslated regions. Cell 38: 275-285.
41. Sasaki, T. (1996). Recent advances in the ultrastructural assessment of osteoclastic resorptive function. Microsc. Res. Tech. 33: 182-191.
42. Schwarzenbach, H., Newell, J. W., and Matthias, P. (1995). Involvement of the Ets family factor Pu.1 in the activation of immunoglobulin promoters. J. Biol. Chem. 270: 898-907.
43. Shi, G. P., Webb, A. C., Foster, K. E., Knoll, J. H. M., Lemere, C. A., Munger, J. S., and Chapman, H. A. (1994). Human cathepsin S: Chromosomal localization, gene structure and tissue distribution. J. Biol. Chem. 269: 11530-11536.
44. Shi, G. P., Chapman, H. A., Bhairi, S. J., DeLeeuw, C., Reddy, V. Y., and Weiss, S. J. (1995). Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett. 357: 129-134.
45. Tezuka, K., Tezuka, Y., Maejima, A., Sato, T., Nemoto, K., Kamioka, H., Hakeda, Y., and Kumegawa, M. (1994). Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem. 269: 1106-1109.
46. Troelstra, C., Hesen, W., Bootsma, D., and Hoeijmakers, H. J. J. (1993). Structure and expression of the excision repair gene ERCC6, involved in the human disorder Cockayne's syndrome group B. Nucleic Acids Res. 21: 419-426.
47. Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., Marine, T. J., Hirota, H., Taga, T., and Kishimoto, T. (1995). Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 182: 1461-1468.
48. Voso, M. T., Burn, T. C., Wulf, G., Lim, B., Leone, G., and Tenen, D. G. (1994). Inhibition of hematopoiesis by competitive binding of transcription factor Pu.1. Proc. Natl. Acad. Sci. USA 91: 7932-7936.
49. Woo, J. T., Yamaguchi, K., Hayama, T., Kobori, T., Sigeizumi, S., Lugimoto, K., Kondo, K., Tsuji, T., Ohba, Y., Tagami, K., and Sumitani, K. (1996). Suppressive effect of N-(benzyloxycarbonyl)-L-phenylalanyl-L-tyrosinal on bone resorption in vitro and in vivo. Eur. J. Pharmacol. 300: 131-135.
50. Xu, L., Thali, M., and Schaffner, W. (1991). Upstream box/TATAbox order is the major determinant of the direction of transcription. Nucleic Acids Res. 19: 6699-6704.
51. Xu, S., Huang, S., and Lo, W. H. (1994). A new approach to gene diagnosis of Duchenne/Becker muscular dystrophy - Amplified fragment length polymorphisms. Chin. Med. Sci J. 9: 137-142.
52. Zhang, D., Hetherington, C., Chen, H., and Tenen, D. G. (1994). The macrophage transcription factor Pu.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell Biol. 14: 373-381.